SCHEMBL25590604

SCHEMBL25590604

Cc1cc(I)ccc1CNC(=O)N1CC(OC(C)C)C1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 7/20 0.53
▸ JAK2 O60674 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ HRH2 P25021 1/20 0.53
▸ CDK7 P50613 1/20 0.53
▸ CD69 Q07108 1/20 0.53
▸ AAK1 Q2M2I8 1/20 0.53
▸ MAP3K19 Q56UN5 1/20 0.53
▸ CDKL2 Q92772 1/20 0.53
▸ RIOK1 Q9BRS2 1/20 0.53
▸ RIOK2 Q9BVS4 1/20 0.53
▸ BMP2K Q9NSY1 1/20 0.53
▸ EPHX2 P34913 4/20 0.39
▸ P2RX7 Q99572 4/20 0.36
▸ CHRNA7 P36544 1/20 0.36
▸ GRIN2B Q13224 2/20 0.35
▸ AVPR2 P30518 1/20 0.35
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2J2 P51589 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16793564 0.86 BTK (0.53) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL18183911 0.80 BTK (0.48) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL25584965 0.79 BTK (0.59) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL16793852 0.79 BTK (0.47) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL20461055 0.79 BTK (0.61) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL16793760 0.77 BTK (0.59) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL29676771 0.77 BTK (0.59) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL29676750 0.77 BTK (0.69) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL29986746 0.77 BTK (0.69) BTKJAK2CYP3A4HRH2CDK7
SCHEMBL20027003 0.77 BTK (0.45) BTKJAK2CYP3A4HRH2CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3444251-B1 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY BIOGEN MA INC (US) 2023-06-07 — — EP disclosed
Send feedback